Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00534118 · ADVERSE EVENTS

Adverse events

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant · Source last updated 2020-08-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
All cause mortality includes individual participants who experienced death due to any cause before 3 years after first DLI and is the only SAE/AE captured per protocol
Other-event reporting threshold
0%

All cause mortality includes individual participants who experienced death due to any cause before 3 years after first DLI

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Multiple DLI

Accruals where the patient received 2-4 donor lymphocyte infusions Arm includes total number of infusions

10 / 150 / 1510 / 15
Single DLI

accruals where the patient received only one donor lymphocyte infusion

7 / 120 / 127 / 12

Group identifiers: EG000: Multiple DLI · EG001: Single DLI

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      10
      num At Risk
      15
      num Events
      10
    2. group Id
      EG001
      num Affected
      7
      num At Risk
      12
      num Events
      7
    term
    All cause mortality by 3 years after first DLI

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Complete source fields
    description
    All cause mortality includes individual participants who experienced death due to any cause before 3 years after first DLI
    event Groups
    1. deaths Num Affected
      10
      deaths Num At Risk
      15
      description
      Accruals where the patient received 2-4 donor lymphocyte infusions Arm includes total number of infusions
      id
      EG000
      other Num Affected
      0
      other Num At Risk
      15
      serious Num Affected
      10
      serious Num At Risk
      15
      title
      Multiple DLI
    2. deaths Num Affected
      7
      deaths Num At Risk
      12
      description
      accruals where the patient received only one donor lymphocyte infusion
      id
      EG001
      other Num Affected
      0
      other Num At Risk
      12
      serious Num Affected
      7
      serious Num At Risk
      12
      title
      Single DLI
    frequency Threshold
    0
    serious Events
    1. assessment Type
      SYSTEMATIC_ASSESSMENT
      organ System
      General disorders
      stats
      1. group Id
        EG000
        num Affected
        10
        num At Risk
        15
        num Events
        10
      2. group Id
        EG001
        num Affected
        7
        num At Risk
        12
        num Events
        7
      term
      All cause mortality by 3 years after first DLI
    time Frame
    All cause mortality includes individual participants who experienced death due to any cause before 3 years after first DLI and is the only SAE/AE captured per protocol

    Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

    Preserved source evidence · Not medical advice